WASHINGTON, July 2 -- National Institutes of Health has issued a notice called: Government Owned Invention Available for License: A Conserved Viral Peptide for Use in Cancer Immunotherapy.
The notice was published in the Federal Register on July 2 by Richard U. Rodriguez, Associate Director, Technology Transfer Center, National Cancer Institute.
Summary: The National Cancer Institute (NCI) seeks research co-development partners and/or licensees for viral peptide (CE1)-based therapeutics for HCC prevention and treatment.
For more information, contact Inquiries related to this license opportunity should be directed to: Kevin Chang, Ph.D, Technology Transfer Manager, NCI, Technology Transfer Center, Email: changke@mail.nih.govor Phone: 240-...